Severe nucleoside-associated lactic acidosis in human immunodeficiency virus–infected patients: report of 12 cases and review of the literature
V Falcó, D Rodríguez, E Ribera… - Clinical infectious …, 2002 - academic.oup.com
Lactic acidosis is a rare but often fatal complication reported in some human
immunodeficiency virus (HIV)–infected patients treated with nucleoside-analogue reverse …
immunodeficiency virus (HIV)–infected patients treated with nucleoside-analogue reverse …
[HTML][HTML] Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection
…, D Podzamczer, D Dalmau, E Ribera… - … England Journal of …, 2003 - Mass Medical Soc
Background We assessed the strategy of substituting nevirapine, efavirenz, or abacavir for a
protease inhibitor in patients infected with human immunodeficiency virus type 1 (HIV-1) in …
protease inhibitor in patients infected with human immunodeficiency virus type 1 (HIV-1) in …
Aortic complications after bicuspid aortic valve replacement: long-term results
CF Russo, S Mazzetti, A Garatti, E Ribera… - The Annals of thoracic …, 2002 - Elsevier
BACKGROUND: Bicuspid aortic valve (BAV) is a risk factor for aortic dissection and
aneurysm. We studied patients with BAV and tricuspid aortic valve (TAV) to evaluate long …
aneurysm. We studied patients with BAV and tricuspid aortic valve (TAV) to evaluate long …
Effectiveness of Cloxacillin with and without Gentamicin in Short-Term Therapy for Right-Sided Staphylococcus aureus Endocarditis: A Randomized, Controlled Trial
E Ribera, J Gomez-Jimenez, E Cortes… - Annals of internal …, 1996 - acpjournals.org
Background: It is often difficult to administer extended antibiotic therapy in the hospital for
right-sided Staphylococcus aureus endocarditis. Although the effectiveness of single-drug …
right-sided Staphylococcus aureus endocarditis. Although the effectiveness of single-drug …
Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients
…, V Falco, S Mauleon, J Andreu, M Crespo, E Ribera… - European …, 2003 - Springer
The aim of this study was to assess the value of high-resolution CT in distinguishing
between Pneumocystis carinii and non-Pneumocystis carinii pneumonia (PCP) in patients …
between Pneumocystis carinii and non-Pneumocystis carinii pneumonia (PCP) in patients …
Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment
Stavudine is a nucleoside analogue used for the treatment of HIV-1 infection, as part of
highly active antiretroviral treatment. In developing countries, stavudine is used widely …
highly active antiretroviral treatment. In developing countries, stavudine is used widely …
[HTML][HTML] Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations
…, J Navarro, A Curran, J Burgos, E Ribera… - PLoS …, 2019 - journals.plos.org
Latency reversal agents (LRAs) have proven to induce HIV-1 transcription in vivo but are
ineffective at decreasing the size of the latent reservoir in antiretroviral treated patients. The …
ineffective at decreasing the size of the latent reservoir in antiretroviral treated patients. The …
Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy
…, AM Planes, O Del Valle, E Ribera… - Clinical Infectious …, 2004 - academic.oup.com
We studied all human immunodeficiency virus (HIV)-infected patients with invasive
pneumococcal disease who received their diagnosis during 1996–2002 to investigate the …
pneumococcal disease who received their diagnosis during 1996–2002 to investigate the …
Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression …
…, F Pulido, S Di Giambenedetto, E Ribera… - Journal of …, 2018 - academic.oup.com
Background Dual therapy (DT) with a ritonavir-boosted PI (PI/r) plus lamivudine has proven
non-inferior (12% margin) to triple therapy (TT) with PI/r plus two nucleos (t) ide reverse …
non-inferior (12% margin) to triple therapy (TT) with PI/r plus two nucleos (t) ide reverse …
The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial
…, C Estany, D Podzamczer, E Ribera… - Clinical Infectious …, 2015 - academic.oup.com
Background. It is unknown if tenofovir disoproxil fumarate (TDF), which is often coformulated
with the lipid-neutral emtricitabine (FTC), has a lipid-lowering effect. Methods. We performed …
with the lipid-neutral emtricitabine (FTC), has a lipid-lowering effect. Methods. We performed …